{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2F360-one-firm.simplecast.com%2Fepisodes%2Fcannabis-deep-dive-feb-16-2021-4ZyEu7Gt","width":444,"version":"1.0","type":"rich","title":"Cannabis Deep Dive (Feb. 16, 2021)","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/53d086a4-c703-4b0c-affe-804f421a73c0/bc7a9eeb-b45c-4b13-9c98-cac9e131e143/for-zoom-backgrounds-5.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/e9bcc28a-4767-439d-988d-045f4db18f89\" height=\"200\" width=\"100%\" title=\"Cannabis Deep Dive (Feb. 16, 2021)\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"On Feb. 16, 361Firm haosts a Deep Dive on the international cannabis and CBD markets in the wake of GW Pharma's acquisition and Tilray’s UK distribution deal. To register, join the Cannabis group on 361’s App (https://361firm.honeycommb.com/groups/cannabis).\n"}